Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1416-1420 (21 June), doi:10.1136/bmj.39542.509444.AE (published 16 June 2008)
Christine Stabell Benn, senior researcher1, Birgitte Rode Diness, clinician1, Adam Roth, clinician1,2, Ernesto Nante, clinician3, Ane Bærent Fisker, student3, Ida Maria Lisse, senior registar 4, Maria Yazdanbakhsh, professor 5, Hilton Whittle, professor 6, Amabelia Rodrigues, research director3, Peter Aaby, director3
1 Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark , 2 Department of Medical Microbiology, Lund University, 205 02 Malmö, Sweden , 3 Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau , 4 Department of Pathology, Herlev University Hospital, 2730 Herlev, Denmark , 5 Department of Immunoparasitology, Leiden University Medical Centre, Leiden 2333 AZ, Netherlands , 6 MRC Laboratories, Fajara, POB 273, Gambia
Correspondence to: C S Benn cb{at}ssi.dk
Design Randomised placebo controlled trial.
Setting Bandim Health Projects demographic surveillance system in Guinea-Bissau, covering approximately 90 000 inhabitants.
Participants 4345 infants due to receive BCG.
Intervention Infants were randomised to 50 000 IU vitamin A or placebo and followed until age 12 months.
Main outcome measure Mortality rate ratios.
Results 174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration.
Conclusions Vitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival.
Trial registration Clinical trials NCT00168597 [ClinicalTrials.gov] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?